The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAnglo Asian Regulatory News (AAZ)

Share Price Information for Anglo Asian (AAZ)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 64.00
Bid: 62.00
Ask: 66.00
Change: 2.50 (4.07%)
Spread: 4.00 (6.452%)
Open: 61.50
High: 65.00
Low: 64.00
Prev. Close: 61.50
AAZ Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Hardman & Co Research: Anglo Asian Mining (AAZ): Prodigious cashflow AND bigger 'system' potential

19 Jun 2019 13:01

Hardman & Co Research Hardman & Co Research: Anglo Asian Mining (AAZ): Prodigious cashflow AND bigger 'system' potential 19-Jun-2019 / 13:00 GMT/BST


Hardman & Co Research: Prodigious cashflow AND bigger "system" potential

Anglo Asian Mining (AAZ) is a highly cash-generative miner of gold, silver and copper from four mines in Azerbaijan, where it has close ties to the government. In 2018, it produced 83,376 of gold equivalent ounces (GEOs), paid its first dividend and had net cash on its balance sheet. At this stage, we have made the highly conservative assumption of no production beyond 2025. Nevertheless, our DCF valuation of 156p reflects AAZ's prodigious cash generation and gold/copper stockpiles. Indeed, we estimate that the company's aggregate underlying free cashflow during 2019-25 will be in excess of its current market capitalisation and the annual free cash yield will average 16.2%. Please click here for the full report:

https://www.hardmanandco.com/research/corporate-research/prodigious-cashflow-and-bigger-system-potential/

To contact us: Hardman & Co 35 New Broad Street London EC2M 1NH www.hardmanandco.comFollow us on Twitter @HardmanandCo Contacts: Paul Mylchreest +44 20 7194 7622 pm@hardmanandco.com

Hardman & Co Research can still be accessed for free after MiFID II. Please click here to read the statement.

About Hardman & Co: For the past 21 years Hardman has been producing specialist research designed to improve investors' understanding of companies, sectors, industries and investment securities. Our analysts are highly experienced in their sectors, and have often been highly rated by professional investors for their knowledge. Our focus is to raise companies' profiles across the UK and abroad with outstanding research, investor engagement programmes and advisory services. Some of our notes have been commissioned by the company which is the subject of the note; this is clearly stated in the disclaimer where this is the case.

Hardman Research Ltd, trading as Hardman & Co, is an appointed representative of Capital Markets Strategy Ltd and is authorised and regulated by the Financial Conduct Authority; our FCA registration number is 600843. Hardman Research Ltd is registered at Companies House with number 8256259.

Our research is provided for the use of the professional investment community, market counterparties and sophisticated and high net worth investors as defined in the rules of the regulatory bodies. It is not intended to be made available to unsophisticated retail investors. Anyone who is unsure of their categorisation should consult their professional advisors. This research is neither an offer, nor a solicitation, to buy or sell any security. Please read the note for the full disclaimer.


Dissemination of a CORPORATE NEWS, transmitted by EQS Group.The issuer is solely responsible for the content of this announcement.


End of Announcement - EQS News Service

827471 19-Jun-2019 

corporate announcement transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.

Date   Source Headline
27th Aug 20084:35 pmRNSPrice Monitoring Extension
21st Aug 20088:42 amRNSHolding(s) in Company
20th Aug 20084:35 pmRNSPrice Monitoring Extension
12th Aug 20084:41 pmRNSSecond Price Monitoring Extn
12th Aug 20084:35 pmRNSPrice Monitoring Extension
1st Aug 20082:30 pmRNSAppointment of CFO
1st Aug 20087:00 amRNSIssue of Equity
31st Jul 20083:32 pmRNSHolding(s) in Company
23rd Jul 200812:09 pmRNSResult of AGM
23rd Jul 20087:00 amRNSPre-AGM Statement
16th Jul 200812:49 pmRNSHolding(s) in Company
30th Jun 20087:00 amRNSNotice of Annual Report and A
27th Jun 200810:22 amRNSIssue of Shares
26th Jun 20087:00 amRNSFinal Results
18th Jun 20083:13 pmRNSHolding(s) in Company
16th Apr 200811:45 amRNSIssue of shares
10th Apr 20087:00 amRNSGedabek & Financing Update
27th Mar 20084:40 pmRNSSecond Price Monitoring Extn
27th Mar 20084:35 pmRNSPrice Monitoring Extension
12th Mar 20085:55 pmRNSHolding(s) in Company
23rd Jan 20084:41 pmRNSSecond Price Monitoring Extn
23rd Jan 20084:35 pmRNSPrice Monitoring Extension
13th Nov 20077:01 amRNSIssue of shares
23rd Oct 20077:02 amRNSAcquires Process Plant
23rd Oct 20077:01 amRNSSale of CIL Plant
1st Oct 20074:36 pmRNSPrice Monitoring Extension
28th Sep 20077:04 amRNSInterim Results
24th Sep 20077:02 amRNSAgreement on Credit Facility
19th Sep 20072:26 pmRNSNotice of Results
9th Aug 20077:00 amRNSCOMPLIANCE WITH AIM RULE 26
27th Jul 20077:01 amRNSAward of Options
19th Jul 20077:01 amRNSAppointment of Chairman
18th Jun 20077:01 amRNSGedabek Project Update
1st Jun 20077:01 amRNSDirectorate Change
25th Apr 20074:54 pmRNSResult of AGM
2nd Apr 20079:12 amRNSAnnual Report and Accounts
19th Mar 20077:03 amRNSFinal Results
14th Mar 20073:20 pmRNSNotice of Results
5th Mar 20077:01 amRNSNotice of Discovery
15th Feb 20077:01 amRNSGedabek Scoping Study
1st Feb 20077:01 amRNSChange of Address
27th Dec 20067:01 amRNSDirectorate Change
20th Dec 200610:14 amRNSTotal Voting Rights
11th Dec 20067:01 amRNSPresentation
1st Dec 20067:01 amRNSGedabek Resource Estimate
16th Nov 20067:01 amRNSGedabek Drilling Update
11th Oct 20067:00 amRNSOperational Update
24th Aug 20067:01 amRNSInterim Results
15th Aug 200610:21 amRNSNotice of Results
31st Jul 200611:40 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.